Endotoxin and Sterility tests to Witness Most Demand in Global Biological Safety Testing Market

All varieties of biopharmaceuticals, including blood and blood products, tissues and tissue products, stem cell products, and vaccines and therapeutics are required to undergo stringent safety testing to win approval from health authorities such as the U.S. FDA and the European Medicines Agency. Biological safety testing services help companies dealing with biopharmaceuticals demonstrate that entities such as cell banks, bulk harvests, viral banks, raw materials obtained from animal origin, and clinical drug batches are free of potential contaminants such as viruses, bacteria, fungi, yeasts, and mycoplasma.

Over the past few years, the applications of biology safety testing have significantly expanded and a number of service providers have entered the market. The demand for biological safety testing services is expected to rise at an excellent pace in the next few years as countries across the globe ramp up efforts to improve their healthcare infrastructures and the consumption of targeted medicines increase.

Transparency Market Research estimates that the market will exhibit a 10% CAGR over the period between 2016 and 2024. As a result, the market, which was pegged at US$1.31 bn in 2015, is expected to rise to US$3.08 bn by 2024.

Obtain Report Details @

In this blog post, Transparency Market Research analysts underscore some of the key trends observed in the global market for biological safety testing in the past few years:

What factors have chiefly contributed towards the overall development of the market in the past few years?

The thriving biopharmaceutical industry and technological advancements aimed at making operations and processes more effective as compared to the past are the two factors to have most significantly impacted the growth dynamics of the global biological safety testing market recently. The market has thrived across developed countries that boast advanced healthcare and pharmaceutical infrastructures. The rising prevalence of a variety of chronic diseases and the resultant rise in demand for biologics across the pharmaceutical industry have also positively influenced the market for biological safety training in the past few years. Moreover, the rising usage of biotechnology techniques in mainstream medical and biological research is also a key factor driving the market.

Which kinds of biological safety tests have led to most lucrative returns over the years?

Biological safety tests are of a variety of kinds, including bioburden tests, sterility tests, adventitious agent detection tests, endotoxin tests, cell line authentication and characterization, toxicity and stability tests, and residual host contamination detection tests. Of these, the segments of sterility and endotoxin tests are expected to dominate the market in terms of demand owing to the increased attention being paid to the aspect of patient safety in the healthcare industry. These tests are also expected to remain the most popular and in-demand tests in the next few years as well, aided by the emergence of several supportive regulatory frameworks.


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports